Roles of vasopressin in renal blood flow and vascular resistance in male mice after treadmill running: A mechanism for ALPE
Physiological Reports · 2025
DOI: 10.14814/phy2.70648 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von Kazutoshi Nomura und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Kanazawa Medical University, Uchinada, Ishikawa, Japan. Hauptthemen laut MEDLINE: Renal Circulation, Vascular Resistance, Vasopressins, Acute Kidney Injury. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant-in-Aid for Scientific Research (KAKENHI), Japan, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Acute renal failure with severe loin pain and patchy renal ischemia after high‐intensity exercise (ALPE) is a rare form of acute kidney injury. This study examined the role of vasopressin and its receptor, AVPR1A, in ALPE using a mouse model of brief high‐intensity treadmill exercise. Hypoxia‐reporter mice received vasopressin after treadmill running (Treadmill + Vasopressin group), whereas controls received vasopressin alone. Renal ischemia and hypoxia were assessed by in vivo imaging system (IVIS) after D‐luciferin injection and confirmed by pimonidazole staining. Renal blood flow and vascular resistance were measured in anesthetized mice. The effects of the AVPR1A antagonist SR49059 were also evaluated. The Treadmill + Vasopressin group showed a rapid decrease in renal blood flow and an increase in vascular resistance compared with the Vasopressin group. Pimonidazole staining revealed marked hypoxia at the corticomedullary junction, which was minimal in controls. Bioluminescence indicated renal hypoxia lasting up to 48 h. SR49059 attenuated these changes, supporting an AVPR1A‐mediated mechanism. These findings implicate vasopressin in the pathogenesis of ALPE via AVPR1A‐dependent vasoconstriction that leads to renal ischemia and support AVPR1A antagonism as a potential therapeutic strategy for ALPE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
- Department of Physiology II, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
- Division of Cell Medicine, Department of Life Science, Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
ORCID-Profile: Keiichiro Okada, Kengo Furuichi
Förderung
- Grant-in-Aid for Scientific Research (KAKENHI), Japan
- Japan Society for the Promotion of Science
Zitieren
APA
Nomura, K., Tanida, M., Akai, R., Yabe, T., Fujii, A., Nomura, K., Okada, K., Okino, K., Hayashi, N., Fujimoto, K., Kurata, Y., Iwawaki, T., & Furuichi, K. (2025). Roles of vasopressin in renal blood flow and vascular resistance in male mice after treadmill running: A mechanism for ALPE. Physiological Reports. https://doi.org/10.14814/phy2.70648
Vancouver
Nomura K, Tanida M, Akai R, Yabe T, Fujii A, Nomura K, et al. Roles of vasopressin in renal blood flow and vascular resistance in male mice after treadmill running: A mechanism for ALPE. Physiological Reports. 2025. doi:10.14814/phy2.70648
BibTeX
@article{Nomura2025,
author = {Nomura, Kazutoshi and Tanida, Mamoru and Akai, Ryoko and Yabe, Tomohisa and Fujii, Ai and Nomura, Kanae and Okada, Keiichiro and Okino, Kazuaki and Hayashi, Norifumi and Fujimoto, Keiji and Kurata, Yasutaka and Iwawaki, Takao and Furuichi, Kengo},
title = {Roles of vasopressin in renal blood flow and vascular resistance in male mice after treadmill running: A mechanism for ALPE},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70648}
}
EUVIMED